Caisse DE Depot ET Placement DU Quebec Takes $5.35 Million Position in Baxter International Inc. $BAX

Key Points

• The Caisse DE Depot ET Placement DU Quebec invested approximately $5.35 million in Baxter International Inc., acquiring 156,254 shares in the first quarter.
• Baxter International reported Q2 earnings of $0.59 per share, missing analyst expectations, with revenue of $2.81 billion, slightly below estimates of $2.82 billion.
• The company declared a quarterly dividend of $0.17 per share, scheduled for payment on October 1st, representing a dividend yield of 2.8%.

Caisse DE Depot ET Placement DU Quebec purchased a new position in Baxter International Inc. (NYSE:BAX - Free Report) in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 156,254 shares of the medical instruments supplier's stock, valued at approximately $5,349,000.

A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. Horizon Investments LLC raised its holdings in shares of Baxter International by 5.0% in the first quarter. Horizon Investments LLC now owns 7,438 shares of the medical instruments supplier's stock worth $255,000 after buying an additional 351 shares during the last quarter. Rothschild Investment LLC raised its holdings in shares of Baxter International by 3.4% in the first quarter. Rothschild Investment LLC now owns 14,479 shares of the medical instruments supplier's stock worth $496,000 after buying an additional 481 shares during the last quarter. Archer Investment Corp raised its holdings in shares of Baxter International by 20.5% in the first quarter. Archer Investment Corp now owns 2,935 shares of the medical instruments supplier's stock worth $100,000 after buying an additional 500 shares during the last quarter. Home Federal Bank of Tennessee raised its holdings in shares of Baxter International by 2.5% in the first quarter. Home Federal Bank of Tennessee now owns 22,600 shares of the medical instruments supplier's stock worth $774,000 after buying an additional 550 shares during the last quarter. Finally, Private Trust Co. NA raised its holdings in shares of Baxter International by 17.3% in the first quarter. Private Trust Co. NA now owns 3,822 shares of the medical instruments supplier's stock worth $131,000 after buying an additional 565 shares during the last quarter. Hedge funds and other institutional investors own 90.19% of the company's stock.

Analyst Upgrades and Downgrades

A number of research analysts have issued reports on the stock. Barclays decreased their price target on shares of Baxter International from $41.00 to $36.00 and set an "overweight" rating for the company in a report on Monday, August 4th. UBS Group decreased their price target on shares of Baxter International from $35.00 to $24.00 and set a "neutral" rating for the company in a report on Monday, August 4th. Wells Fargo & Company reduced their target price on shares of Baxter International from $33.00 to $24.00 and set an "equal weight" rating for the company in a report on Friday, August 1st. The Goldman Sachs Group cut shares of Baxter International from a "buy" rating to a "neutral" rating and set a $25.00 target price for the company. in a report on Friday, August 1st. Finally, Citigroup reduced their target price on shares of Baxter International from $34.00 to $32.00 and set a "neutral" rating for the company in a report on Wednesday, July 9th. Three research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, Baxter International has an average rating of "Hold" and a consensus price target of $30.11.

Baxter International Stock Performance

BAX traded down $0.55 on Tuesday, reaching $24.15. The stock had a trading volume of 10,205,522 shares, compared to its average volume of 5,360,191. Baxter International Inc. has a 12-month low of $21.33 and a 12-month high of $40.49. The company has a current ratio of 2.30, a quick ratio of 1.49 and a debt-to-equity ratio of 1.30. The business's 50-day moving average price is $26.81 and its two-hundred day moving average price is $29.91. The company has a market cap of $12.40 billion, a P/E ratio of -80.37, a price-to-earnings-growth ratio of 0.80 and a beta of 0.60.

Baxter International (NYSE:BAX - Get Free Report) last released its quarterly earnings data on Thursday, July 31st. The medical instruments supplier reported $0.59 earnings per share for the quarter, missing analysts' consensus estimates of $0.60 by ($0.01). Baxter International had a negative net margin of 1.42% and a positive return on equity of 16.96%. The firm had revenue of $2.81 billion during the quarter, compared to analysts' expectations of $2.82 billion. During the same period in the previous year, the firm posted $0.68 EPS. The firm's quarterly revenue was up 4.3% on a year-over-year basis. Baxter International has set its Q3 2025 guidance at 0.580-0.620 EPS. FY 2025 guidance at 2.420-2.520 EPS. Sell-side analysts forecast that Baxter International Inc. will post 2.48 earnings per share for the current year.

Baxter International Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, October 1st. Stockholders of record on Friday, August 29th will be given a $0.17 dividend. The ex-dividend date is Friday, August 29th. This represents a $0.68 annualized dividend and a dividend yield of 2.8%. Baxter International's dividend payout ratio (DPR) is -226.67%.

About Baxter International

Baxter International Inc, through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories.